{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:53:52Z","timestamp":1792252432200,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jvc.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:19:19Z","timestamp":1778761159000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival of dogs with myxomatous mitral valve disease administered preclinical pimobendan in comparison to pimobendan-na\u00efve dogs from the onset of congestive heart failure"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-997X","authenticated-orcid":false,"given":"G.","family":"McAulay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-8251","authenticated-orcid":false,"given":"J.","family":"Dukes-McEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7803-4038","authenticated-orcid":false,"given":"E.","family":"Dutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4275-2621","authenticated-orcid":false,"given":"A.","family":"Jakubczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1980-5410","authenticated-orcid":false,"given":"D.","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3754-6026","authenticated-orcid":false,"given":"E.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1371-3092","authenticated-orcid":false,"given":"W.","family":"Yangwanitset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1890-6161","authenticated-orcid":false,"given":"M.","family":"Hezzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jvc.2012.01.011","article-title":"Historical review, epidemiology and natural history of degenerative mitral valve disease","volume":"14","author":"Borgarelli","year":"2012","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of Pimobendan or Benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study","volume":"22","author":"H\u00e4ggstr\u00f6m","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs","volume":"33","author":"Keene","year":"2019","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/jvim.14586","article-title":"Effect of Pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study\u2014A randomized clinical trial","volume":"30","author":"Boswood","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","article-title":"Allometric scaling of m-mode cardiac measurements in normal adult dogs","volume":"18","author":"Cornell","year":"2004","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/vetsci11120594","article-title":"Echocardiographic changes in dogs with stage B2 myxomatous mitral valve disease treated with pimobendan monotherapy","volume":"11","author":"Crosland","year":"2024","journal-title":"Vet Sci"},{"key":"10.1016\/j.jvc.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jvim.14885","article-title":"Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with preclinical myxomatous mitral valve disease receiving pimobendan or placebo: the EPIC study","volume":"32","author":"Boswood","year":"2018","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jvim.12181","article-title":"Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study","volume":"27","author":"Haggstrom","year":"2013","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jvc.2022.02.001","article-title":"The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: baseline treatment characteristics","volume":"41","author":"Franchini","year":"2022","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jvc.2021.11.003","article-title":"Analysis of canine cardiovascular therapeutic agent prescriptions using electronic health records in primary care veterinary practices in the United Kingdom","volume":"39","author":"Bode","year":"2022","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2026.05.001_bib11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1292\/jvms.65.1057","article-title":"The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats","volume":"65","author":"Uechi","year":"2003","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.jvc.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","article-title":"Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in Cavalier King Charles Spaniels with and without left atrial enlargement","volume":"43","author":"Hansson","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"10.1016\/j.jvc.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1939-1676.2010.0592.x","article-title":"Detection of congestive heart failure in dogs by doppler echocardiography","volume":"24","author":"Schober","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1292\/jvms.69.373","article-title":"Effects of Pimobendan for mitral valve regurgitation in dogs","volume":"69","author":"Kanno","year":"2007","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.jvc.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jvc.2022.12.002","article-title":"Echocardiographic evaluation of regurgitant fraction in dogs with subclinical myxomatous mitral valve disease: method comparison, effects of pimobendan, and reproducibility","volume":"45","author":"Ellis-Reis","year":"2023","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2026.05.001_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.646437","article-title":"Acute effects of Pimobendan on cardiac function in dogs with tachycardia induced dilated cardiomyopathy: a randomized, Placebo-Controlled, crossover study","volume":"8","author":"Abbott-Johnson","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.jvc.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/jvim.16131","article-title":"The mitral INsufficiency echocardiographic score: a severity classification of myxomatous mitral valve disease in dogs","volume":"35","author":"Vezzosi","year":"2021","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib18","first-page":"1","article-title":"Comparison of the effects of dual, triple, and quadruple medical therapy on cardiac death in a retrospective cohort of dogs with myxomatous mitral valve disease at American college of veterinary internal medicine stage C: is more necessarily better?","author":"Romito","year":"2025","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2026.05.001_bib19","first-page":"1219","article-title":"Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases","volume":"52","author":"Madron","year":"2011","journal-title":"Can Vet J"},{"key":"10.1016\/j.jvc.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/jvim.15863","article-title":"Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: the VALVEtrial","volume":"34","author":"Wess","year":"2020","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/01652176.2025.2560412","article-title":"Impact of administering cardiac medication to small-breed dogs with preclinical myxomatous mitral valve disease on survival after congestive heart failure onset","volume":"45","author":"Park","year":"2025","journal-title":"Vet Q"},{"key":"10.1016\/j.jvc.2026.05.001_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1292\/jvms.16-0069","article-title":"Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure","volume":"79","author":"Mizuno","year":"2016","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.jvc.2026.05.001_bib23","first-page":"75","article-title":"Assessment of lung ultrasound B-Lines in dogs with different stages of chronic valvular heart disease","volume":"21","author":"Vezzosi","year":"2017","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib24","first-page":"93","article-title":"Validation and preliminary data from a health-related quality of life questionnaire for owners of dogs with cardiac disease","volume":"17","author":"Freeman","year":"2020","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jvim.15126","article-title":"Clinical findings and survival time in dogs with advanced heart failure","volume":"32","author":"Beaumier","year":"2018","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib26","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/jvim.15864","article-title":"Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: the CARPODIEM study","volume":"34","author":"Besche","year":"2020","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1107724","article-title":"Quantification of primary mitral regurgitation by echocardiography: a practical appraisal","volume":"10","author":"Altes","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jvc.2026.05.001_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jvc.2015.11.002","article-title":"Assessment of mitral valve morphology using three-dimensional echocardiography. Feasibility and reference values","volume":"18","author":"Menciotti","year":"2016","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2026.05.001_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1939-1676.2007.tb02958.x","article-title":"Chordae tendineae rupture in dogs with degenerative mitral valve disease: prevalence, survival, and prognostic factors (114 cases, 2001\u20132006)","volume":"21","author":"Serres","year":"2007","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273426000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1760273426000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:33:00Z","timestamp":1792251180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1760273426000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S1760273426000470"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2026.05.001","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival of dogs with myxomatous mitral valve disease administered preclinical pimobendan in comparison to pimobendan-na\u00efve dogs from the onset of congestive heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}